cart medical
Advancing immune cell therapy with state-of-the-art technologies in a 2,200 square meter GMP and research facility.
Advancing immune cell therapy with state-of-the-art technologies in a 2,200 square meter GMP and research facility.
cart medical is a high-tech company founded in 2017 that focuses on advancing immune cell therapy utilizing cutting-edge technologies. The company operates in the Health Care and Information Technology sectors. Its slogan emphasizes its commitment to leveraging state-of-the-art technologies within a spacious 2,200 square meter GMP and research facility. In March 2022, the company secured a significant CNY70.00M Series A investment from 冠亚投资控股有限公司, Unifortune, Nanjing Chengyi Investment, and Haihui Investment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | CNY70.00M | 4 |
|
09 Mar 2022 |
| Series A | Unknown | 1 | BioVenture | 20 Mar 2019 |
No recent news or press coverage available for cart medical.
We care about your data, and we'd love to use cookies make your experience better.
